Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Steven J. Mento"'
Publikováno v:
Journal of Virological Methods. 73:31-39
A new method of producing vesicular stomatitis virus (VSV) G protein pseudotyped retroviral vectors is described. In this method, stocks of VSV-G pseudotyped vector were reproducibly obtained by infecting an env − , human, retroviral vector produce
Autor:
Mangala J. Hariharan, Sondra Schlesinger, David A. Driver, Kay Townsend, Stephen M. W. Chang, Silvia Perri, Steven J. Mento, Barbara A. Belli, John M. Polo, Ilya Frolov, Scott Sherrill, Thomas W. Dubensky, Douglas J. Jolly
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 96(8)
Alphavirus vectors are being developed for possible human vaccine and gene therapy applications. We have sought to advance this field by devising DNA-based vectors and approaches for the production of recombinant vector particles. In this work, we ge
Autor:
Timothy Fong, Carlos E. Ibanez, L. M. Karavodin, K. Chong, Joan M. Robbins, Douglas J. Jolly, Steven J. Mento, D. Hsu
Publikováno v:
Human gene therapy. 9(15)
The generation of a lasting systemic immune response is a primary goal for cancer immunotherapy. Here we examine the ability of high-titer IFN-gamma retroviral vector injected into an accessible tumor to generate significant antitumor responses at a
Autor:
Douglas J. Jolly, Lee William Tsung-Liang, Steven J. Mento, David R. Milich, Stephen M. W. Chang, Kay Townsend, Catharina Hultgren, Greg Ronlov, Janice Hughes, Joanne O'Dea, Jean Alfonso, Ali Javadian, Carol-Gay Anderson, Matti Sällberg, Krishna K. Murthy, Robert W. Eason
Publikováno v:
Human gene therapy. 9(12)
Cytotoxic T lymphocyte (CTL) activity and CD4+ helper T cell responses to the hepatitis B virus (HBV) core antigen (HBcAg) have been implicated in clearance of acute and chronic HBV infections. We showed that intramuscular injections of a novel recom
Autor:
James Hanlon, James E. McCormack, Edgar Kamantigue, Mary Petrowski, Steven J. Mento, Nancy Sajjadi, Douglas J. Jolly, Nicholas J. DePolo, Darlene Martineau, Wolfgang M. Klump
Publikováno v:
Human gene therapy. 8(10)
Gene delivery via murine-based recombinant retroviral vectors is currently widely used in gene therapy clinical trials. The vectors are engineered to be replication defective by replacing the structural and nonstructural genes of a cloned infectious
Autor:
J. O'dea, S. M. W. Chang, Kay Townsend, Douglas J. Jolly, Theresa A. Banks, Matti Sällberg, D. A. Driver, Sybille L. Sauter, Wen-Hsin Lee, David R. Milich, Steven J. Mento
Cytotoxic T-lymphocyte (CTL) activity appears to play an important role in resolving hepatitis B virus (HBV) infection, and the ability to induce such responses remains an important goal for developing effective immunotherapeutics. A panel of recombi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3890678980d0afd305e03d234738fb75
https://europepmc.org/articles/PMC191480/
https://europepmc.org/articles/PMC191480/
Autor:
D. A. Driver, John M. Polo, Theresa A. Banks, Sunil Chada, Duane Brumm, Carlos E. San Diego Ibanez, Thomas W. Dubensky, S. M. W. Chang, Steven J. Mento, B. A. Belli, Douglas J. Jolly, E. M. Latham
Publikováno v:
Journal of virology. 70(1)
Several DNA-based Sindbis virus vectors were constructed to investigate the feasibility and potential applications for initiating the virus life cycle in cells transfected directly with plasmid DNA. These vectors, when transfected into mammalian cell
Autor:
Richard Haubrich, Steven J. Mento, John F. Warner, Jay Merritt, Douglas J. Jolly, Jeff Galpin
Publikováno v:
Annals of the New York Academy of Sciences. 772
Autor:
Douglas J. Jolly, Theresa A. Banks, John M. Polo, Duane Brumm, Sunil Chada, Thomas W. Dubensky, Emi M. Latham, David A. Driver, Stephen M. W. Chang, Steven J. Mento, Barbara A. Belli
Publikováno v:
Annals of the New York Academy of Sciences. 772
Autor:
Gloria Peters, Ulrike H.m. Ziegner, Jack R. Barber, Cheryl Bohart, David E. Hartnett, Wolfgang M. Klump, Charles E. Prussak, Douglas J. Jolly, Jeffrey Galpin, Nancy Sajjadi, Steven J. Mento, Bruce Merchant, John F. Warner
Publikováno v:
AIDS (London, England). 9(1)
Objective : To demonstrate the safety and enhancement of HIV-1-specific immune responses in HIV-infected asymptomatic patients following treatment with retroviral vector (Retrovector®)-transduced autologous fibroblasts (VTAF) expressing HIV-1 IIIB E